• Atomo to present at IRD Invest Virtual Investor Conference

    Australianrapid blood test company Atomo Diagnostics Limited (ASX: AT1)(Atomo)is pleased to announce thatManaging Director & CEO, John Kelly, will present at the IRD Invest virtual investor conference on Wednesday, 29 July 2020 at 11.00 am AEST
    View Event
  • 264 < Discover more events
    Interested in the ASX listed companies in this event? Check out the latest news, announcements, financial data, and capital raise history for: